MenB Meningococcal B vaccine
The 2026 private infant schedule shows doses at 10 and 18 weeks, followed by a booster at 12–15 months.
The routine South African public childhood immunisation schedule from birth to 12 years, plus school campaigns and commonly offered private add-ons.
This is a guide to commonly offered additions, not one fixed schedule. Private clinics may also use different brands or wider-valency pneumococcal vaccines for routine doses; those can be alternatives rather than extra injections.
The 2026 private infant schedule shows doses at 10 and 18 weeks, followed by a booster at 12–15 months.
Given every year. A child younger than 9 receiving flu vaccine for the first time usually needs two doses one month apart.
The private infant schedule shows two doses, with at least three months between them.
Private MMR adds mumps protection to the public measles-rubella programme. The 2026 schedule shows a first dose at 12 months and a second at 6 years.
Two paediatric doses are commonly given, with the second at least six months after the first.
Product and prior infection matter. A two-dose schedule commonly starts at 12–15 months, with the routine second dose at 6 years; a clinician may use a shorter permitted interval.
Private HPV vaccination is available to both sexes. Product-labelled schedules generally use two doses six months apart at ages 9–13/14; older or immunocompromised patients need an individual schedule.
Travel vaccines and extra doses for children with particular medical risks are not shown here. Ask a doctor or clinic nurse to reconcile the public and private records so doses are not unnecessarily repeated.
Routine childhood immunisations are free at public clinics. Bring your child's Road to Health Booklet to every visit. If any doses were missed, ask a clinic nurse for an individual catch-up plan rather than restarting the schedule.
Vaccine products have different minimum ages and intervals. A healthcare professional should make the final plan from your child's Road to Health Booklet, private-clinic record, health risks and previous doses.
Reviewed 10 August 2026.